Polidocanol is a medicine used to numb areas of your body. It's often used to make veins smaller or to help stop bleeding. It works by temporarily blocking nerve signals, making the area feel less sensitive. It's used for things like varicose veins or treating bleeding from esophageal varices.
Every report comes from a Lived member, sent anonymously.
Have you tried Polidocanol for Varicose Veins?
Polidocanol is a sclerosing agent: a medicine injected into unwanted leg veins to make them close and fade. This treatment is called sclerotherapy. In the US it is sold under two brand names that treat different kinds of veins. Asclera is a liquid used for spider veins (tiny red or purple veins 1 mm wide or less) and reticular veins (slightly larger blue-green veins, 1 to 3 mm wide) on the legs. It has not been studied in larger varicose veins, and people usually treat these small veins because of how they look. Varithena is a prescription foam for larger problems in the great saphenous vein, the long surface vein that runs up the inside of the leg, along with its side branches and the bulging varicose veins they feed. When the valves in this vein fail, blood pools in the leg and can cause heaviness, aching, swelling, throbbing and itching. Varithena is approved to improve both those symptoms and how the veins look. Other ways to close this vein include heat-based treatment with radiofrequency or laser energy and surgery.
Polidocanol works like a detergent on the inner lining of the vein. It damages that lining, which makes the vein wall clamp down and causes a clot to form inside the treated vein. Over the following weeks and months, the body replaces the sealed vein with scar tissue and reabsorbs it. The drug is inactivated once it mixes with flowing blood, which keeps its effect mostly near the injection site. Varithena is made into a fine foam using oxygen. The foam pushes blood out of a large vein so the drug touches the vein wall directly rather than being diluted.
Polidocanol is given only by a clinician, as an injection into a vein during an office visit. Asclera comes in two strengths (0.5% for spider veins, 1% for reticular veins) and is injected through a very fine needle in small amounts at several spots, with a limit on the total amount per session. Varithena 1% foam is injected through a small tube placed in the vein while the clinician watches on ultrasound. Numbing medicine may be used at the needle site, but sedation is not needed. Compression and walking are part of the treatment, not optional extras. Right after the injections, the leg is wrapped or fitted with a compression stocking and you walk for 10 to 20 minutes while staff watch for an allergic reaction. After Asclera, stockings are typically worn around the clock for 2 to 3 days and then during the day for 2 to 3 weeks; after Varithena, bandages stay on and dry for 48 hours and stockings are worn continuously for 2 weeks. Staying active with daily walks, and avoiding long stretches of sitting, lowers the chance of a blood clot. Many people need more than one session. Asclera sessions are usually 1 to 2 weeks apart, and Varithena sessions at least 5 days apart.
Most side effects are at the injection sites: bruising, tenderness, itching, warmth and brown or reddish discoloration along the treated vein. After Varithena, leg pain or discomfort is common and usually settles within a week. A firm, tender lump can form where trapped blood has clotted inside the treated vein; the clinician can drain it to ease discomfort and reduce staining. Skin darkening can take months to fade. Some people develop a blush of new tiny vessels near the treated area. Less often, polidocanol causes serious reactions. Severe allergic reactions, including fatal anaphylaxis, have occurred, which is why you are observed after the injections. If the drug leaks outside the vein or enters an artery, it can damage the skin and tissue around it. A clot can also extend into a deep vein. New swelling of the calf or whole leg, or pain deep in the calf, should be reported to the treating clinic right away. Sudden shortness of breath or chest pain after treatment can mean a clot has reached the lungs (pulmonary embolism) and needs emergency care: call 911. Strokes have been reported rarely, mostly with foam made by mixing the drug with room air.
Polidocanol is not used in people with a known allergy to it or who currently have a blood clot in a vein or the lungs. Tell the clinician if you have had a deep vein thrombosis (a clot in a deep leg vein) or pulmonary embolism, if you have trouble moving around, or if you have had major surgery, a long hospital stay or a pregnancy in the past 3 months, because each raises the risk of a clot after treatment. People with significant artery disease in the legs face a higher risk of tissue damage and may not be good candidates. No drug interactions have been formally studied. It still helps for the clinician to know about blood thinners and any condition that makes wearing tight compression stockings difficult. Treating small leg veins during pregnancy offers little benefit, because veins that appear in pregnancy often shrink on their own after delivery. Waiting is usually sensible. The FDA-approved Varithena foam is made with a controlled gas mix. Foam that a clinic prepares by shaking liquid polidocanol with room air has not been shown to be safe and effective, and the Asclera label advises against it because of reports of air bubbles reaching the brain or heart. It is reasonable to ask which preparation your clinic uses.
Treated spider and reticular veins usually fade over several weeks. In the main Asclera study, about 95% of people had good improvement or complete clearing at 12 weeks, and results held at 26 weeks. For the great saphenous vein, Varithena trials measured improvement at 8 weeks, when about two thirds to three quarters of people reported clearly less heaviness, aching and swelling, compared with far fewer on placebo. Plan on some bruising and discoloration that can take weeks to months to clear, and on following the compression and activity instructions. For a few days after Asclera, avoid heavy exercise, sunbathing, long flights and hot baths or saunas; after Varithena, avoid heavy exercise for a week and long periods of inactivity for a month. Sclerotherapy closes the veins that are treated, but it does not stop new ones from forming, and long-term recurrence has not been well studied. Many people return for touch-up sessions over time. For larger varicose veins, the clinician will usually check the leg with ultrasound before and after treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Polidocanol, what you've noticed, or ask the community a question.